Nature’s Miracle Holding Inc. has executed a landmark $20 million XRP treasury allocation through an equity financing agreement with GHS Investments, triggering a 150% surge in its stock price and underscoring growing corporate cryptocurrency adoption.
The strategic move coincides with new regulatory clarity provided by the recently enacted GENIUS Act, which is encouraging businesses to integrate digital assets like XRP into treasury operations. Companies including VivoPower International and Wellgistics Health have announced significant XRP commitments, signaling broader institutional acceptance.
XRP’s price simultaneously reached a record high of $3.66, supported by nearly $3 billion in exchange transfers reflecting robust trading activity. Nature’s Miracle CEO James Li emphasized XRP’s utility for corporate treasuries, noting staking’s potential for additional yield generation amid evolving payment infrastructure.